(Q43714790)

26 November 2017

title

Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis (English)

1 reference

26 November 2017

0 references

D M Nguyen

1

1 reference

26 November 2017

D Lorang

2

1 reference

26 November 2017

G A Chen

3

1 reference

26 November 2017

J H Stewart

4

1 reference

26 November 2017

E Tabibi

5

1 reference

26 November 2017

D S Schrump

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

The Annals of Thoracic Surgery

26 November 2017

published in

1 reference

26 November 2017

volume

72

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

371-8; discussion 378-9

1 reference

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Antisense blockade of p21/WAF1 decreases radiation-induced G2 arrest in esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902787-4

10.1016/S0003-4975(01)02787-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference